LivaNova (LIVN) Cash from Investing Activities Growth (3y) (2019 - 2026)
LivaNova (LIVN) Cash from Investing Activities Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | -17.67% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | -68.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -68.64% |
| Mar 31, 2026 | -8.28% |
| Dec 31, 2025 | -40.32% |
| Sep 30, 2025 | -58.13% |
| Jun 30, 2025 | 17.80% |
| Mar 31, 2025 | -24.69% |
| Dec 31, 2024 | -43.40% |
| Sep 30, 2024 | -44.17% |
| Jun 30, 2024 | -30.49% |
| Mar 31, 2024 | 13.58% |
| Dec 31, 2023 | -12.58% |
| Sep 30, 2023 | 1.97% |
| Jun 30, 2023 | 16.86% |
| Mar 31, 2023 | -1.19% |
| Dec 31, 2022 | -0.56% |
| Sep 30, 2022 | 10.25% |
| Jun 30, 2022 | 1.34% |
| Mar 31, 2022 | 0.95% |
| Dec 31, 2021 | 34.88% |
| Sep 30, 2021 | 24.25% |